Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ.
Gao Y, et al. Among authors: nakamura k.
Nat Immunol. 2024 Mar 21. doi: 10.1038/s41590-024-01799-9. Online ahead of print.
Nat Immunol. 2024.
PMID: 38514890
No abstract available.